U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07229651) titled 'Metformin in Parkinson Disease' on Nov. 13.
Brief Summary: The clinical manifestations of Parkinson's disease (PD), a chronic neurodegenerative condition, include resting tremor, hypokinesia, bradykinesia, stiffness and postural instability. These motor symptoms are caused by a selective loss and degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNpc) region, which leads to a dopamine (DA) insufficiency in the striatum
Study Start Date: Nov. 10
Study Type: INTERVENTIONAL
Condition:
Parkinson Disease
Intervention:
DRUG: Levodopa Carbidopa
Carbidopa/levodopa, also known as levocarb and co-careldopa, is...